Invasive fungal disease in PICU: epidemiology and risk factors
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Candida and Aspergillus spp. are the most common agents responsible for invasive fungal infections in children. They are associated with a high mortality and morbidity rate as well as high health care costs. An important increase in their incidence has been observed during the past two decades. In infants and children, invasive candidiasis is five times more frequent than invasive aspergillosis. Candida sp. represents the third most common agent found in healthcare-associated bloodstream infections in children. Invasive aspergillosis is more often associated with hematological malignancies and solid tumors. Recommendations concerning prophylactic treatment for invasive aspergillosis have been recently published by the Infectious Diseases Society of America. Candida albicans is the main Candida sp. associated with invasive candidiasis in children, even if a strong trend toward the emergence of Candida non-albicans has been observed. The epidemiology and the risk factors for invasive fungal infections are quite different if considering previously healthy children hospitalized in the pediatric intensive care unit, or children with a malignancy or a severe hematological disease (leukemia). In children, the mortality rate for invasive aspergillosis is 2.5 to 3.5 higher than for invasive candidiasis (respectively 70% vs. 20% and 30%).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191 · cited 3×
“The recommendations given by the Infectious Diseases Society of America are very clear regarding central line replacement in case of ICI: “Central venous catheters should be removed when candidemia is documented, if at all possible”[9].”
BackgroundInfluentialCandida Colonization and Subsequent Infections in Critically III Surgical Patients
Pittet, D., Monod, M., Suter, P. M., Frenk, E., & Auckenthaler, R. (1994) · Annals of Surgery · doi:10.1097/00000658-199412000-00008 · Cited by 798 · cited 2×
“showed the value of using a Candida colonization index (ratio of the number of distinct, non-blood, body sites, screening positive for Candida spp to the total number of distinct body sites tested) to identify colonized patients who should be treated preemptively with antifungal therapy [23].”
BackgroundMethodZaoutis, T. E., Argon, J., Chu, J., Berlin, J. A., Walsh, T. J., & Feudtner, C. (2005) · Clinical Infectious Diseases · doi:10.1086/496922 · Cited by 784
Self-citationLeón, C., Ruiz-Santana, S., Saavedra, P., Almirante, B., Nolla-Salas, J., Álvarez-Lerma, F., Garnacho-Montero, J., & León, M. Á. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000202208.37364.7d · Cited by 659 · cited 1×
“In the literature regarding adults, many publications have reported scores or indexes based on localization of Candida colonization, and the presence or not of clinical signs, to identify people at risk of developing ICI [21-23].”
BackgroundLortholary, O., Desnos-Ollivier, M., Sitbon, K., Fontanet, A., Bretagne, S., & Dromer, F. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01128-10 · Cited by 362
Prophylactic antifungal therapy in the intensive care unit
Weinstein, R. A., Rex, J. H., & Sobel, J. D. (2001) · Clinical Infectious Diseases · doi:10.1086/319763 · Cited by 155 · cited 1×
“Based on data from studies in adult patients, some authors have suggested using antifungal prophylaxis in patients for whom the risk of candidemia is higher than 10% [20].”
Background
Cited by
Epidemiology of Invasive Fungal Disease in Children
Pana, Z. D., Roilides, E., Warris, A., Groll, A. H., & Zaoutis, T. (2017) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/pix046 · Cited by 260
Self-citationRybak, J. M., Ge, W., Wiederhold, N. P., Parker, J. E., Kelly, S. L., Rogers, P. D., & Fortwendel, J. R. (2019) · mBio · doi:10.1128/mbio.00437-19 · Cited by 130
Emerging threat of triazole-resistant Aspergillus fumigatus
Rybak, J. M., Fortwendel, J. R., & Rogers, P. D. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky517 · Cited by 80
Zomorodian, K., Bandegani, A., Mirhendi, H., Pakshir, K., Alinejhad, N., & Poostforoush Fard, A. (2016) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.28666 · Cited by 20
Metadata
- Authors
- Brissaud, O., Guichoux, J., Harambat, J., Tandonnet, O., & Zaoutis, T.
- Venue
- Annals of Intensive Care
- Publisher
- Elsevier BV
- Published
- 2012-02-22
- Volume
- 2
- Issue
- 1
- Pages
- 6-6
- ISSN
- 2110-5820 (ISSN-L)
- OpenAlex
- W2104433838
- Cited by
- 102
- References
- 6
- FWCI
- 5.26
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Invasive fungal disease in PICU: epidemiology and risk factors. https://app.cochat.ai/papers/10.1186/2110-5820-2-6
- The paper
- Brissaud, O., Guichoux, J., Harambat, J., Tandonnet, O., & Zaoutis, T. (2012). Invasive fungal disease in PICU: epidemiology and risk factors. Annals of Intensive Care. https://doi.org/10.1186/2110-5820-2-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.